BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38550428)

  • 1. A Case of Myosin Heavy Chain 9-Related Disorder Following Splenectomy Due to Misdiagnosis of Idiopathic Thrombocytopenic Purpura.
    Arslan Davulcu E; Karaca E; Akad Soyer N
    Cureus; 2024 Feb; 16(2):e55064. PubMed ID: 38550428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of
    Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
    Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
    [No Abstract]   [Full Text] [Related]  

  • 3. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
    Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
    Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years].
    Cherif H; Greinacher A; Lubenow N
    Lakartidningen; 2018 Mar; 115():. PubMed ID: 29533410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the hidden clues: Döhle body-like inclusions as morphological markers for MYH9-related disorders: A case report.
    Zhang Y; Zuo Z; Yu W; Xu A
    Medicine (Baltimore); 2023 Dec; 102(51):e36735. PubMed ID: 38134071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYH9-Related Disorder (MYH9-RD): An Under-Recognized Family of Giants Among the Inherited Thrombocytopenias.
    Khor ZX; Liam CCK
    Cureus; 2024 Feb; 16(2):e55174. PubMed ID: 38558752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R1933X mutation in the MYH9 gene in May-Hegglin anomaly mimicking idiopathic thrombocytopenic purpura.
    Sung CC; Lin SH; Chao TK; Chen YC
    J Formos Med Assoc; 2014 Jan; 113(1):56-9. PubMed ID: 23759689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag to Treat Thrombocytopenia During Last Month of Pregnancy in a Woman With MYH9-Related Disease: A Case Report.
    Favier R; De Carne C; Elefant E; Lapusneanu R; Gkalea V; Rigouzzo A
    A A Pract; 2018 Jan; 10(1):10-12. PubMed ID: 28795988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYH9-related disorders display heterogeneous kidney involvement and outcome.
    Tabibzadeh N; Fleury D; Labatut D; Bridoux F; Lionet A; Jourde-Chiche N; Vrtovsnik F; Schlegel N; Vanhille P
    Clin Kidney J; 2019 Aug; 12(4):494-502. PubMed ID: 31384440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin heavy chain-9-related disorders (MYH9-RD): a case report.
    Vassallo D; Erekosima I; Kanigicherla D; O'Riordan E; Uthappa P; Chrysochou C
    Clin Kidney J; 2013 Oct; 6(5):516-8. PubMed ID: 26015866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic delay of MYH9-related disorder in Japan.
    Sakamoto A; Uchiyama T; Kaname T; Iguchi A; Ohara O; Ishimura M; Onum M; Kunishima S; Ishiguro A
    Br J Haematol; 2024 Apr; ():. PubMed ID: 38650331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature.
    Ai Q; Zhao L; Yin J; Jiang L; Jin Q; Hu X; Chen S
    Medicine (Baltimore); 2020 Jan; 99(4):e18887. PubMed ID: 31977897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Biopsy-induced Hematoma and Infection in a Patient with Asymptomatic May-Hegglin Anomaly.
    Matsumoto T; Yanagihara T; Yoshizaki K; Tsuchiya M; Terasaki M; Nagahama K; Shimizu A; Kunishima S; Maeda M
    J Nippon Med Sch; 2021 Dec; 88(6):579-584. PubMed ID: 33692298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia.
    Thurlapati A; Guntupalli S; Mansour R
    Cureus; 2021 Aug; 13(8):e16964. PubMed ID: 34527454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias.
    Balduini CL; Pecci A; Savoia A
    Br J Haematol; 2011 Jul; 154(2):161-74. PubMed ID: 21542825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia.
    Bastida JM; Gonzalez-Porras JR; Rivera J; Lozano ML
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia.
    Favier R; Feriel J; Favier M; Denoyelle F; Martignetti JA
    Pediatrics; 2013 Sep; 132(3):e793-5. PubMed ID: 23940247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and genetic features of seven children with MYH9-related disease].
    Hu Y; Ma JY; Liu HQ; Yang BX; Zhao SS; Zhang JL; Wu RH
    Zhonghua Er Ke Za Zhi; 2021 Nov; 59(11):968-972. PubMed ID: 34711033
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
    Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
    Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP).
    Boyers D; Jia X; Crowther M; Jenkinson D; Fraser C; Mowatt G
    Health Technol Assess; 2011 May; 15 Suppl 1():23-32. PubMed ID: 21609650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.